1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Kilitch Drugs (India) Limited

Kilitch Drugs (India) Limited

KILITCH.NS
Kilitch Drugs (India) LimitedIN flagNational Stock Exchange of India
192.51
INR
+4.06
- -
6.73BMarket Cap

Total Valuation

Kilitch Drugs (India) Limited carries a market capitalization of 6.73B, placing it among publicly traded companies globally. Its enterprise value stands at 4.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap6.73B
Enterprise Value4.39B

Share Statistics

Kilitch Drugs (India) Limited currently has 34.96M shares outstanding.

Shares Outstanding34.96M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Kilitch Drugs (India) Limited trades at a trailing price-to-earnings ratio of 13.98. The price-to-sales ratio is 1.79, and the price-to-book ratio stands at 12.06.

PE Ratio13.98
PS Ratio1.79
PB Ratio12.06
P/TBV Ratio1.63
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Kilitch Drugs (India) Limited trades at an EV/EBITDA multiple of 13.31 and an EV/FCF ratio of 103.42. The EV/Sales ratio of 1.86 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.31 provides insight into valuation relative to core operating earnings.

EV / Sales1.86
EV / EBITDA13.31
EV / EBIT13.31
EV / FCF103.42

Financial Position

Kilitch Drugs (India) Limited maintains a current ratio of 1.83, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 32.04, indicating elevated leverage, while an interest coverage ratio of 5.93 demonstrates adequate ability to service its debt obligations.

Current Ratio1.83
Quick Ratio0.57
Debt / Equity32.04
Debt / EBITDA2.69
Interest Coverage5.93

Financial Efficiency

Kilitch Drugs (India) Limited posts a return on equity of 115.05 and a return on invested capital of 6.93.

Return on Equity (ROE)115.05
Return on Assets (ROA)7.04
Return on Invested Capital (ROIC)6.93
Return on Capital Employed (ROCE)31.82
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover10.34

Taxes

Over the trailing twelve months, Kilitch Drugs (India) Limited has paid 91.54M in income taxes, reflecting an effective tax rate of 23.68.

Income Tax91.54M
Effective Tax Rate23.68

Stock Price Statistics

Kilitch Drugs (India) Limited's stock has declined approximately -8.44628% over the past 52 weeks. The 50-day moving average sits at 174.98, while the 200-day moving average is 169.33.

Beta (5Y)N/A
52-Week Price Change-8.44628%
50-Day Moving Average174.98
200-Day Moving Average169.33
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Kilitch Drugs (India) Limited generated 2.35B in revenue and converted that into 301.66M in net income, yielding earnings per share of 8.71. EBITDA reached 329.77M, while operating income came in at 329.77M.

Revenue2.35B
Gross Profit1.09B
Operating Income329.77M
Pretax Income386.55M
Net Income301.66M
EBITDA329.77M
EBIT329.77M
Earnings Per Share (EPS)8.71

Balance Sheet

Kilitch Drugs (India) Limited holds 687.72M in cash and equivalents against 887.09M in total debt, resulting in a net debt position of 729.35M. Total book value stands at 349.62M, with working capital of 1.01B providing operational flexibility.

Cash & Cash Equivalents687.72M
Total Debt887.09M
Net Debt729.35M
Equity (Book Value)349.62M
Book Value Per Share10.32
Working Capital1.01B

Margins

Kilitch Drugs (India) Limited operates with a gross margin of 46.12, reflecting its pricing power and cost economics. The operating margin of 14.00 and net profit margin of 12.81 provide insight into operational efficiency.

Gross Margin46.12
Operating Margin14.00
Pretax Margin16.42
Profit Margin12.81
EBITDA Margin14.00

Stock Splits

Kilitch Drugs (India) Limited's most recent stock split took place on March 24, 2026 with a 1:2 split ratio.

Last Split Date3/24/2026
Split Ratio1:2

Scores

Kilitch Drugs (India) Limited posts an Altman Z-Score of 2.46, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.46